GLENMARK PHARMACEUTICALS LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,194 INR | -1.30% |
|
+2.91% | +39.84% |
| May. 30 | Transcript : Glenmark Pharmaceuticals Limited - Analyst/Investor Day | |
| May. 29 | Assertio Therapeutics Names Brendan O'Grady as Chief Executive | MT |
Quotes 5-day view
Delayed Quote NSE India S.E.| 2024-06-04 | 2024-06-05 | 2024-06-06 | 2024-06-07 | |
|---|---|---|---|---|
| Last | 1122.35 ₹ | 1183.55 ₹ | 1209.85 ₹ | 1194.15 ₹ |
| Volume | 2 199 037 | 935 489 | 769 796 | 818 364 |
| Change | -4.58% | +5.45% | +2.22% | -1.30% |
| Opening | 1,176.20 | 1,135.00 | 1,184.55 | 1,213.00 |
| High | 1,189.00 | 1,203.00 | 1,216.15 | 1,220.95 |
| Low | 1,037.15 | 1,109.05 | 1,164.25 | 1,188.00 |
Performance
| 1 day | -1.30% | ||
| 1 week | +2.91% | ||
| Current month | +2.91% | ||
| 1 month | +17.56% | ||
| 3 months | +25.01% | ||
| 6 months | +45.29% | ||
| Current year | +39.84% | ||
| 1 year | +80.10% | ||
| 3 years | +93.76% | ||
| 5 years | +126.44% | ||
| 10 years | +113.36% |
Volumes
marketsDaily volume
818 364
Estimated daily volume
818 364
Avg. Volume 20 sessions
1 578 711
Daily volume ratio
0.52
Avg. Volume 20 sessions INR
1 885 217 740.65
Avg. Volume 20 sessions USD
22 577 367.66
Record volume 1
89 266 590
Record volume 2
65 123 680
Record volume 3
39 631 540
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Capitalization (INR)
341 478 682 532
Capitalization (USD)
4 089 548 702
Net sales (INR)
118 130 970 000
Net sales (USD)
1 414 736 497
Number of employees
15 556
Sales / Employee (INR)
7 593 917
Sales / Employee (USD)
90 945
Free-Float
49.03 %
Free-Float capitalization (INR)
167 440 603 448
Free-Float capitalization (USD)
2 005 268 667
Average Daily Capital Traded
0.55%
Highs and lows
1 week
1 037.15
1 220.95
1 month
985.201 220.95
Current year
771.001 220.95
1 year
621.801 220.95
3 years
348.501 220.95
5 years
161.651 220.95
10 years
161.651 262.90
Indicators
Moving average 5 days
1 170.46
Moving average 20 days
1 074.93
Moving average 50 days
1 043.18
Moving average 100 days
970.70
Price spread / (MMA5)
-1.98%
Price spread / (MMA20)
-9.98%
Price spread / (MMA50)
-12.64%
Price spread / (MMA100)
-18.71%
STIM
RSI 9 days
67.33
RSI 14 days
66.45
Sector Comparison - Generic Pharmaceuticals
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -1.30% | +2.91% | +39.84% | +80.10% | 4.09B | ||
| +2.32% | +3.22% | +19.64% | +48.52% | 42.33B | ||
| -0.77% | -0.94% | +21.25% | +20.05% | 22.47B | ||
| +1.67% | +0.37% | +18.92% | - | 15.25B | ||
| +1.03% | +5.56% | +53.19% | +104.97% | 12.6B | ||
| -.--% | +0.14% | - | - | 6.79B | ||
| +0.38% | -1.69% | -11.11% | -17.55% | 6.71B | ||
| -.--% | -1.95% | - | - | 5.73B | ||
| +0.36% | +0.43% | +14.68% | +31.96% | 5.47B | ||
| -0.05% | +2.80% | +6.91% | +9.54% | 4.78B | ||
| +2.26% | +4.62% | +23.64% | +20.35% | 4.46B | ||
| -1.77% | -0.26% | -16.53% | -19.66% | 4.18B | ||
| +5.17% | +3.75% | +16.18% | +66.96% | 3.47B | ||
| -3.25% | -10.46% | +2.85% | +81.94% | 2.92B | ||
| +0.32% | +5.04% | +1.63% | +15.48% | 2.83B | ||
| +0.68% | +4.41% | -16.03% | -1.01% | 2.73B | ||
| Average | +0.44% | +0.79% | +12.50% | +33.97% | ||
| Weighted average by Cap. | +0.90% | +1.15% | +18.85% | +40.14% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
008791e.hkNlwE2VcA9DWdWQGgePAcGJb8bDUJ_boRTfHzuv05s.yjAw9Tv2BEcXMJPTfVe5Sp7QQp72HfvvkUu6JnHpv-7rIgyOF_EATg81og
| Date | Price | Volume | Daily volume |
|---|---|---|---|
| 06:23:36 am | 1,194 | 54 | 818,364 |
| 06:21:44 am | 1,194 | 8 | 818,310 |
| 06:19:27 am | 1,194 | 4 | 818,302 |
| 06:18:06 am | 1,194 | 1 | 818,298 |
| 06:10:02 am | 1,194 | 10 | 818,297 |
| 06:00:03 am | 1,198 | 39 | 818,287 |
| 05:59:59 am | 1,198 | 111 | 818,248 |
| 05:59:52 am | 1,198 | 245 | 818,137 |
Monthly variations
Annual change
| 2024 | +39.84% | ||
| 2023 | +101.33% | ||
| 2022 | -19.75% | ||
| 2021 | +7.10% | ||
| 2020 | +42.03% | ||
| 2019 | -49.87% | ||
| 2018 | +16.53% | ||
| 2017 | -33.06% | ||
| 2016 | -3.63% | ||
| 2015 | +19.70% | ||
| 2014 | +44.27% | ||
| 2013 | +1.00% | ||
| 2012 | +80.05% | ||
| 2011 | -18.93% | ||
| 2010 | +31.27% | ||
| 2009 | -6.84% | ||
| 2008 | -50.32% | ||
| 2007 | +97.78% | ||
| 2006 | +92.22% | ||
| 2005 | +29.33% | ||
| 2004 | +238.85% | ||
| 2003 | +198.25% | ||
| 2002 | +26.86% | ||
| 2001 | -7.37% | ||
| 2000 | -62.36% |
- Stock Market
- Equities
- GLENMARK Stock
- Quotes Glenmark Pharmaceuticals Limited
